All News

Matching consumer demand with R&D may seem like an obvious starting point for innovation. But it has proven a transient goal for many countries and companies.

Europe’s small biotechs have leapt to take advantage of the European Medicines Agency’s (EMEA) office for SMEs, according to a review of its first year in operation.

Two of Europe’s gene therapy pioneers have reported significant progress in the last week, bringing commercial gene therapy products yet closer to reality.

The DETECT-it 2 project aims to find opportunities for SMEs to participate in the first call of the 7th Framework Programme.

2006 was a record year for patents covering financial innovations.

The locals may not like him, but were it not for Borat who would pay any attention to a report on Science and Technology in Kazakhstan?